AI-generated analysis. Always verify with the original filing.
Pliant Therapeutics, Inc. issued a press release on March 11, 2026, announcing the Company’s financial results under Item 2.02. The filing includes Exhibit 99.1, the press release, and references Item 9.01 for financial statements and exhibits.
Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition . On March 11, 2026, Pliant Therapeutics, Inc. (the "Company") issued a press release announcing the Company’s fin
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued by the Company dated March 11, 2026 104 Cover Page Interactiv